The 'vascular' aetiology of headache is questioned. An alternative hyp
othesis based on sensitisation of sensory nerve endings by neurogenic
plasma extravasation is discussed. The development of drugs which sele
ctively inhibit the release of vasoactive neuropeptides from perivascu
lar sensory nerves may benefit patients with head pain from a variety
of causes.